H

HUTCHMED (China) Limited
D

HCM

15.440
USD
-0.28
(-1.78%)
مغلق
حجم التداول
860
الربح لكل سهم
1
العائد الربحي
-
P/E
77
حجم السوق
2,639,911,545
أصول ذات صلة
ABT
ABT
0.130
(0.10%)
132.390 USD
AMGN
AMGN
-0.48
(-0.17%)
289.50 USD
BDX
BDX
-1.320
(-0.78%)
168.650 USD
BMY
BMY
-0.360
(-0.76%)
46.855 USD
DHR
DHR
-1.370
(-0.70%)
194.410 USD
GSK
GSK
-1.075
(-2.71%)
38.640 USD
PFE
PFE
-0.110
(-0.46%)
23.885 USD
SNY
SNY
-0.630
(-1.31%)
47.610 USD
TMO
TMO
2.26
(0.58%)
392.53 USD
المزيد
الأخبار المقالات

العنوان: HUTCHMED (China) Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolioof several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.